PHIO PHARMACEUTICALS CORP. Prepaid Expense and Other Assets, Current
PHIO PHARMACEUTICALS CORP. (PHIO) had Prepaid Expense and Other Assets, Current of $1.30 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.30M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $371.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $445.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $788.00K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $1.30M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $371.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $445.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $788.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $519.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $158.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $354.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $474.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $594.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $373.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $832.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $871.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $678.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $319.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $615.00K 10-K · filed 2024-04-01 |
| 2021-12-31 | $620.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $871.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.68M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $577.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $870.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $702.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $640.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $267.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $316.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $533.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $507.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $117.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $221.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $332.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $459.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $206.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $201.00K 10-K · filed 2019-03-27 |
| 2016-12-31 | $150.00K 10-K · filed 2018-03-26 |
| 2015-09-30 | $432.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $718.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $351.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $442.00K 10-Q · filed 2015-11-12 |
| 2014-09-30 | $510.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $367.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $226.00K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $303.00K 10-K · filed 2015-03-30 |
| 2013-09-30 | $181.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $209.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $102.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $212.00K 10-K · filed 2014-03-28 |
| 2012-09-30 | $144.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $162.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $58.00K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $186.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |